Ibrutinib as a Potential Therapeutic for Cocaine Use Disorder (CUD)
Clemson University and Emory University researchers have partnered up to uncover the efficacy that Ibrutinib can have in targeting and reversing the expression of cocaine addiction genes in human meso-cortico-limbic circuitry.Inventor: Robert Anholt and Trudy Mackay
Published: 10/26/2021